Bharat Book

Report On Vaccines 2012 World Market Analysis, Key Players, Trends, Pediatric and Adult

Press Release   •   Oct 05, 2012 11:36 IST

This report examines the market for vaccines used in humans to previous various types of disease. It covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable, such as Alzheimer’s disease, diabetes, Ebola infection, Epstein-Barr virus (EBV) infection, ETEC infection, heart attach, Helicobacter pylori infection, multiple sclerosis, Parkinson’s disease, West Nile virus (WNV) infection, etc.; vaccines that address these and other not-yet-vaccine-preventable conditions are discussed in Kalorama’s new report, “What's Next in Vaccines.”
 The vaccine industry has seen changes in the past year, and these are covered in this report Vaccines 2012: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry. The high growth rates and successful launch of several products recently have kept interest in the global vaccine market high. The global market for vaccines experienced strong growth through 2011 and this is expected to continue through the forecast period. Growth is being fueled by new product introductions and rising usage in all regions. Business Report
 Included in this report are current market size and forecast for the following vaccines:
 Pediatric Vaccines:
 Other Pediatric
 Adult Vaccines: Cervical Cancer
 Travel; DT; Misc.
 Kalorama has expanded the global perspective of this report in this edition, including estimates of vaccine sales (pediatric and adult segments) in the following regions:

 Rest of North Amer.
 South America
 Rest of World
 Despite ongoing improvements in pediatric vaccination, it is estimated that at least two million children die each year from diseases that could have been prevented by already existing vaccines. This problem is most significant in low income countries, with the health disparity between rich and poor countries resulting in average life spans of about 77 and 52 years, respectively. In addition to this high death toll, millions more suffer disability and illness because they have not been immunized. Adult immunization is an important, but frequently overlooked, part of patient care. Vaccination programs typically focus on children, yet adults in industrialized countries are more likely to die as a result of vaccine-preventable diseases than are children.
 Key issues in the global vaccine market today include product safety, refusal to immunize, supply shortages, the use of vaccines to prevent pandemics and address bioterrorism, and innovations in vaccine delivery systems.The following issues are discussed in this report.
 Vaccine Safety
 Refusal to Immunize
 Post-Licensure Surveillance
 The Future of Vaccine Safety
 Vaccine Shortages
 Preventing Pandemics
 Project Bioshield Act
 National Bio and Agro-Defense Facility
 DNA Vaccination
 Mucosal Delivery
 Intranasal Delivery
 Vaccine Patches
 Vaccine Chips and Microneedles
 Innovations in Vaccine Production
 Nanoparticle Systems
 Vaccination protects not only individuals, but also entire communities from diseases spread by person-to-person transmission.For example, vaccination can prevent about 50% of deaths from pneumococcal disease and 80% of deaths from influenza-related complications in the elderly. Pharmacoeconomic studies have demonstrated the value of influenza and pneumococcal vaccines; however, immunization rates for these diseases continue to be low in the elderly populations. This report includes profiles of the key players in vaccines, including:
 AlphaVax, Inc.
 Bavarian Nordic A/S
 Baxter Healthcare
 Bharat Biotech
 Crucell /Johnson & Johnson
 Emergent biosolutions
 Merck & Co. Inc
 Sanofi Pasteur
The Global Vaccine Industry Scope and Methodology
 Pediatric Preventative Vaccines
 The Market
 Adult Preventative Vaccines
 The Market
 Total Market
 Issues and Trends
A Brief History: The Development of Vaccines
 The Immune Response
 Mechanism of Action
 Types of Vaccines
 Attenuated (Weakened) Live Viruses
 Killed (Inactivated) Viruses
 Toxoid Vaccines
 Genetically Engineered/Modified Vaccines
 Vaccine Approval Process
 Childhood Immunization in the United States
 Childhood Immunization Rates
 Challenges to the Vaccine Delivery System
 The Effect of U.S. Healthcare Reform
 Recommended Childhood Immunization Schedule
 State Immunization Recommendations
 United Nations Initiatives
 Pediatric Vaccine Products
 Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
 Haemophilus Influenzae Type B
 Hepatitis A
 Measles, Mumps and Rubella
 Meningococcal Disease
 Pneumococcal Conjugate
 Pediatric Vaccines in Development
 Cost of Vaccines in the United States
 The World Market for Pediatric Preventive Vaccines
 Total Market Size and Forecast
 Hepatitis Vaccine Market
 For more information kindly visit :
Vaccines 2012 World Market Analysis, Key Players, Trends, Pediatric and Adult
 Bharat Book Bureau
 Ph.: + 91 22 27810772 / 27810773
 Fax: + 91 22 27812290
 Follow us on twitter:!/Sandhya3B

Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.